PAION is a specialty pharmaceutical company that develops innovative products for sedation and anesthesia including commercialization.  

 

Learn more About PAION

Remimazolam

PAION's lead compound, Remimazolam, is an ultra-short-acting intravenous Benzodiazepine sedative and anesthetic that is currently in Phase III clinical development for procedural sedation. Remimazolam has been investigated in more than 1,000 patients worldwide. 

PAION's Remimazolam

Headline data Phase III bronchoscopy

Invitation to Earning Call and Webcast, 29 June 2017, 2 p.m. CEST (1 p.m. BST, 9 a.m. EDT)

To access the English call, please click the following link (external provider).  

Please chose the appropriate number: 
Germany +49 (0) 69 7104 45598
UK +44 (0) 20 3003 2666
US +1 212 999 6659
(other countries: please use the UK number)

Password: "PAION"

news

06/28/2017

Ad hoc release: PAION reports positive headline data in U.S. Phase III trial...

PAION reports positive headline data in U.S. Phase III trial with...

Read more
06/28/2017

Press Release: PAION reports positive headline data in U.S. Phase III trial with...

PAION AG: PAION reports positive headline data in U.S. Phase III...

Read more
05/17/2017

Press Release: PAION AG: Annual General Meeting approves all agenda items and...

PAION AG: Annual General Meeting approves all agenda items and...

Read more
03/09/2017

Press Release: PAION AG: Change in Management Board

PAION AG: Change in Management Board

Read more
02/28/2017

Press Release: PAION AG announces successful completion of capital increase with...

PAION AG announces successful completion of capital increase with...

Read more
02/07/2017

Press Release: PAION AG: Capital increase; preliminary, unaudited key group...

PAION AG: Capital increase; preliminary, unaudited key Group...

Read more
12/21/2016

Press Release: PAION announces clinical development progress with remimazolam by...

PAION announces clinical development progress with remimazolam by...

Read more
10/19/2016

Press Release: Positive Remimazolam phase III colonoscopy results presented at...

Positive Remimazolam phase III colonoscopy results presented at...

Read more
09/22/2016

Press Release: Remimazolam Phase III colonoscopy data to be presented at the...

Remimazolam Phase III colonoscopy data to be presented at the...

Read more
09/06/2016

Press Release: PAION announces clinical development progress with remimazolam by...

PAION announces clinical development progress with remimazolam by...

Read more
06/29/2016

Press Release: PAION completes private placement in the amount of EUR 9.6...

PAION completes private placement in the amount of EUR 9.6...

Read more
06/19/2016

Press Release: PAION reports positive remimazolam headline data in pivotal U.S....

PAION reports positive remimazolam headline data in pivotal U.S....

Read more
04/11/2016

Press Release: PAION successfully completes patient recruitment in Phase III...

PAION successfully completes patient recruitment in Phase III...

Read more

PAION Chart